This disclosure relates to implantable medical leads, and particularly to implantable medical leads that have outwardly deployable electrodes.
Recent efforts in the medical field continue to focus on the delivery of therapy in the form of electrical stimulation to precise locations within the human body. Therapy originates from an implanted or externally-worn source device, which may be an electrical pulse generator. Therapy is applied through one or more implanted leads that communicate with the source device and include one or more therapy delivery sites for delivering therapy to precise locations within the body. In electrical therapy systems, delivery sites take the form of one or more electrodes wired to the source device. In spinal cord simulation (SCS) techniques, for example, electrical stimulation is provided to precise locations near the human spinal cord through a lead that is usually deployed in the epidural space of the spinal cord. Such techniques have proven effective in treating or managing disease and acute and chronic pain conditions.
Percutaneous leads are small diameter leads that may be inserted into the human body, usually by passing through a Tuohy (non-coring) needle which includes a central lumen through which the lead is guided. Percutaneous leads may be inserted into the body with a minimum of trauma to surrounding tissue. On the other hand, the types of lead structure, including the electrodes, that may be incorporated into percutaneous leads is limited because the lead diameter or cross-section must be small enough to permit the lead to pass through the Tuohy needle.
Recently, the use of “paddle” leads, like Model 3586 Resume® Lead or Model 3982 SymMix® Lead of Medtronic, Inc., which offer enhanced therapy control over percutaneous leads, have become popular among clinicians. Paddle leads include a generally two-dimensional set of electrodes on one side for providing electrical therapy to excitable tissue of the body. Through selective programmed polarity (i.e., negative cathode, positive anode or off) of particular electrodes, electric current can be “steered” toward or away from particular tissue within the spinal cord or other body areas. This feature permits adjustment of the recruitment areas after the lead has been positioned in the body and therefore provides a level of adjustment for less than ideal lead placement. Additionally, the value of a transverse tripole group of electrodes has been demonstrated for spinal cord stimulation. This approach allows shielding of lateral nervous tissue with anodes, like the dorsal roots, and steering of fields in the middle under a central cathode by use of two simultaneous electrical pulses of different amplitudes.
One feature recognized in known paddle leads used for SCS is that their installation, repositioning and removal necessitates laminectomies, which are major back surgeries involving removal of part of the vertebral bone. Laminectomies are required because paddle leads have a relatively large transverse cross-sectional area compared to percutaneous leads. Thus, implantation, repositioning and removal require a sufficiently sized passage through the vertebral bone.
Another feature with paddle leads is that optimal positioning may be difficult during implant. For example, the transverse tripole leads described above work optimally if the central cathode is positioned coincident with the physiological midline of the spinal cord. Such placement can be challenging because the doctor cannot see the spinal cord through the dura during implant. Moreover, lead shifting may occur subsequent to implant, thereby affecting the efficacy of the therapy delivered from the lead.
Another feature recognized with paddle leads is that the lead position may change, sometimes solely caused by patient movement. For example, when a patient lies down, the spacing between an epidural lead and the spinal cord decreases to a large extent, so that it is often necessary to lower the amplitude of the stimulation by as much as half. It is also believed that steering effects of a tripole lead might also be affected if the cerebrospinal fluid (“CSF”) width changes dramatically, or if due to patient twisting or activity, the orientation between the lead and spinal cord changes.
Among other things, this disclosure describes a lead structure for stimulation of excitable tissue surfaces which combines the features offered by percutaneous leads with respect to minimized trauma during insertion, repositioning and removal with the advantages offered by paddle-type leads with respect to increased efficacy, ability to provide electrodes in places lateral to the axis of the lead and tailoring of treatment. Exemplary embodiments of this disclosure relate to implantable leads that have portions with electrodes that may be expanded, retracted or adjusted after implantation in the human body. Some illustrative mechanisms for accomplishing such expansion, retraction or adjustment of such leads are also described.
Exemplary embodiments of the disclosure also provide a lead structure which permits adjustment of the lead dimensions and therefore the delivery site location in situ for enhanced control of the therapy being applied to the excitable body tissues.
Exemplary embodiments of the disclosure include an implantable therapy lead having an elongate central body. These embodiments also include at least one extendable member that moves from a retracted position within, or relative to, the elongate central body to an extended position where at least a portion of the extendable member laterally extends beyond the central body. Electrodes may be disposed on the elongate central body and the extendable member. In some embodiments, an electrode on the extendable member is oriented so that it is parallel to an electrode on the central body when the extendable member is in the extended position. The lead may further include a second extendable member that extends to an extended position generally opposite to the extended position of the other extendable member.
In some embodiments, the extendable member includes a gear that engages a worm gear located at the end of a flexible actuator. The flexible actuator is capable of causing the extendable member to move from its retracted position to its extended position by rotating the flexible actuator.
In various embodiments, the extendable member has a lever portion having a flexible actuator secured to the lever portion. The flexible actuator is capable of causing the extendable member to move from its retracted position to its extended position by pulling on the flexible actuator. In some of such embodiments, the lead includes an insulating conduit for containing conductors that electrically couple electrodes of the lead to contacts of the lead. The flexible actuator may also be contained within the insulating conduit with adequate freedom of movement to allow an operator to caused the extendable member to move from its retracted position to its extended position by pulling on the flexible actuator.
In numerous embodiments, the extendable member has a lever portion having a flexible actuator secured to the lever portion. The flexible actuator is secured to the extendable member and is capable of causing the extendable member to move from its extended position to its retracted position by pulling on the flexible retractor.
In various embodiments, the extendable member includes an actuation surface and the lead further includes a movable stylet with a driver, which may be on the distal end of the stylet, that interacts with the actuation surface to cause the extendable member to move from its retracted position to its extended position by pushing on the stylet.
In some embodiments, the implantable medical lead has two rows of electrodes on the central body and at least two electrodes on the extendable member. An electrode on the extendable member is oriented so that it is aligned with a row of therapy delivery electrodes on the central body when the extendable member is in the extended position.
In many embodiments, the extendable member slides out from, or relative to, the central body in a direction generally perpendicular to the axis of the central body. In some cases, this may include a flexible actuator secured to the extendable member in such a way that pulling on the flexible actuator caused the extendable member to slide out from the central body. In other cases, a thermal deployment actuator that recovers its programmed shape may cause the extendable member to move out from the central body.
In various embodiments, an implantable medical lead includes an elongate central body having an axis and a first extendable member pivotably moveable relative to the central body such that a portion of the extendable member is configured to move from a retracted position relative to the axis of the elongate central body to an extended position where the portion of the extendable member extends laterally beyond the central body. The lead includes a first electrode disposed on the central body and second and third electrodes disposed on the extendable member. The lead is configured such that the centers of the first, second and third electrodes are linearly arranged when the extendable member is in the extended position. The lead may also include a second extendable member with an electrode disposed thereon. The second extendable member may pivot and extend in a manner generally opposite than the first extendable member. In an extended position, the center of the electrode of the second extendable member may be linearly arranged with the centers of the first, second and third electrodes.
In some exemplary embodiments of the disclosure, a method for providing therapy to a targeted tissue of a patient includes inserting a conduit having a central lumen into a patient. The method also includes implanting a lead into the patient by passing it through the central lumen of the conduit. The lead has an elongate central body with an electrode thereon and at least one extendable member having an electrode thereon. The extendable member is capable of pivoting from a retracted position within the elongate central body to an extended position. The extendable member is then deployed to the extended position to form an electrode array that includes the electrode on the central body and the electrode on the extendable member. The proximal end of the lead is then coupled to a therapy delivery device and the therapy delivery device is operated to provide treatment therapy though the electrode array. The conduit employed in this method could be a needle, a catheter, or other conduit known in the art. The therapy delivery device may be an implantable device, and the method may further include implanting the device.
In various embodiments in accordance with the disclosure, a system for treating a patient using electrical energy includes a therapy delivery device capable of generating electrical energy. The system also includes a lead having electrical conductors capable of transmitting the electrical energy. The lead has an elongate central body and at least one extendable member that pivots from a retracted position within, or relative to, the elongate central body to an extended position where at least a portion of the extendable member extends laterally beyond the central body. Electrodes are disposed on the elongate central body and the extendable member and connected to the electrical conductors. In various embodiments, an electrode on the extendable member is oriented so that it is parallel to a therapy delivery electrode on the central body when the extendable member is in the extended position.
One or more embodiments of leads, methods or systems described herein may have one or more of the following exemplary benefits relative to existing leads, systems and methods:
1. The spacing of electrodes on an extendable member or central body can be matched to important dimensions of the tissue affected, e.g., the width of the Cerebro-Spinal Fluid (CSF) between the dura and the spinal cord.
2. As the dimensions of a lead tip are changed, the locations of the electrodes relative to the tissue affected may be advantageously altered. For example, as a paddle's width is increased the paddle will move toward the spinal cord in the semicircular dorsal part of the epidural space.
3. In cases where the bones or fluid compartments have large widths (e.g., CSF depth at spinal level T7 or T8) or are too wide in a particular patient, the electrode span can be increased appropriately to ensure effective therapy.
4. Changes in paddle width and the accompanying medial and lateral movement of the sites can have a beneficial effect on the therapy. For example, the ability to stimulate only the medial dorsal columns versus the more lateral dorsal roots may provide enhanced therapeutic results.
5. As the patient ages, their pathological condition changes, their degree of fibrosis or scar tissue changes, or the effects of the therapy change, adjustments of the extendable member might restore or maintain the benefit.
6. Because of the ability to adjust the extendable member after implantation, it may be possible to optimize the benefits and minimize undesirable side effects.
7. By changing the position of the extendable member, it may be possible to avoid surgery to replace or reposition the lead.
8. By changing the position of the extendable member, it may be possible to position the electrodes optimally relative to important physiological locations, e.g., the physiological midline of nervous tissue.
9. It may be possible to minimize the use of energy by optimizing efficiency of therapy delivery through adjustment of the extendable member. This may increase battery life, a key concern for implantable devices.
10. There may be minimal insertion trauma and operating room time and resources needed if it is possible to place a lead with percutaneous techniques, and then expand it in situ.
11. Repositioning of a lead with an extendable member can be done without laminectomy. Removal may also be made quicker and less traumatic.
The accompanying drawings which are incorporated into and form a part of the specification, illustrate several embodiments of the present disclosure and, together with the description, serve to explain the principles of the disclosure. The drawings are only for the purpose of illustrating embodiments of the disclosure and are not to be construed as limiting the disclosure.
The drawings presented herein are schematic and are not necessarily to scale. Like numbers used in the figures refer to like components, steps and the like. However, it will be understood that the use of a number to refer to a component in a given figure is not intended to limit the component in another figure labeled with the same number. In addition, the use of different numbers to refer to components is not intended to indicate that the different numbered components cannot be the same or similar.
In the following detailed description, reference is made to the accompanying drawings that form a part hereof, and in which are shown by way of illustration several embodiments of devices, systems and methods. It is to be understood that other embodiments are contemplated and may be made without departing from the scope or spirit of the present disclosure. The following detailed description, therefore, is not to be taken in a limiting sense.
All scientific and technical terms used herein have meanings commonly used in the art unless otherwise specified. The definitions provided herein are to facilitate understanding of certain terms used frequently herein and are not meant to limit the scope of the present disclosure.
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” encompass embodiments having plural referents, unless the content clearly dictates otherwise.
As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise. As used herein, “have”, “having”, “include”, “including”, “comprise”, “comprising” or the like are used in their open ended sense, and generally mean “including, but not limited to.”
Any direction referred to herein, such as “top,” “bottom,” “left,” “right,” “upper,” “lower,” “above,” below,” and other directions and orientations are described herein for clarity in reference to the figures and are not to be limiting of an actual device or system or use of the device or system. Devices or systems as described herein may be used in a number of directions and orientations.
The present disclosure relates to, among other things, a lead for stimulation of excitable tissue surfaces, which leads combine the features offered by percutaneous leads with respect to minimized trauma during insertion, repositioning and removal with the advantages offered by paddle-type leads with respect to increased efficacy, ability to provide electrodes in places lateral to the axis of the lead and tailoring of treatment. Exemplary embodiments of this disclosure relate to implantable leads that have portions with electrodes that may be expanded, retracted or adjusted after implantation in the human body. Some illustrative mechanisms for accomplishing such expansion, retraction or adjustment of such leads are also described.
Referring now to
In the exemplary embodiment shown in
In the exemplary embodiment shown in
The embodiment shown in
The embodiment depicted in
The flexible actuator 40 could be fixedly attached to the worm gear 110, or the flexible actuator 40 could have a non-circular cross section, at least at the distal end, that could be inserted into a opening on the end of the worm gear 110 of a similar size and dimension. In this way the flexible actuator 40 could be removed from the lead after the extendable member 20 has been deployed and reinserted if retraction or adjustment of the extendable member 20 position is desired.
As with embodiments in accordance with
The thermal deployment actuator 160 may be actuated by use of an electrical signal that heats the element due to electrical resistance. The thermal deployment actuator 160 may be designed with a system of levers to provide mechanical advantage if necessary. The extendable member 20 or the central body 10 may have pins or slots to help the extendable member 20 deploy in a direction generally perpendicular to the axis of the central body.
Once in position within the patient, for example in the epidural space of the spine, a lead in accordance with embodiments of the disclosure may be deployed out of a Tuohy needle or other conduit. The extendable member 20 of the lead may be deployed in any of the manners described above to create an electrode array capable of tissue stimulation similar in effectiveness to stimulation using a more traditional paddle-type lead without the invasiveness of a laminectomy.
Referring now to
In the depicted embodiment, the electrodes 30 of the extendable members 20 are generally parallel to the electrodes 30 of the elongate body 10 when the extendable members are in an extended position (see
Any suitable mechanism may be employed to move the extendable members 20 depicted in
Those skilled in the art will recognize that the preferred embodiments may be altered or amended without departing from the true spirit and scope of the disclosure, as defined in the accompanying claims.
This application claims priority to U.S. Provisional Patent Application No. 61/110,160, filed on Oct. 31, 2008, which application is hereby incorporated herein by reference in its entirety to the extent that it is not inconsistent with the present disclosure.
Number | Date | Country | |
---|---|---|---|
61110160 | Oct 2008 | US |